Kyowa Kirin Co Ltd
DUS:KY4
Relative Value
The Relative Value of one
KY4
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 14.4 EUR,
Kyowa Kirin Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
KY4 Competitors Multiples
Kyowa Kirin Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Kyowa Kirin Co Ltd
DUS:KY4
|
1.5T EUR | 2.9 | 21.7 | 11.1 | 14.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
959.3B USD | 14.7 | 46.5 | 31.3 | 33.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.3B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.8B CHF | 4.8 | 31.1 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
238.2B GBP | 5.5 | 31.6 | 17.4 | 24.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
242.2B CHF | 5.5 | 22.2 | 13.7 | 17.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
305.1B USD | 4.7 | 16.7 | 10.4 | 12.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4.3 | 13 | 9.5 | 11.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.4B USD | 2.4 | 19.5 | 7.3 | 9.7 | |
| UK |
|
GSK plc
XETRA:GS71
|
103.6B EUR | 2.8 | 15.8 | 8 | 11.3 |